Summary
Scientists are developing a pill called LOY-002 to help dogs live longer by slowing down their aging process. The new treatment, targeting a hormone linked to aging in dogs, could get approval from the FDA and become available by the end of 2026.
Key Facts
- A new pill, LOY-002, is being developed to extend the lifespan of dogs.
- The pill targets the hormone IGF-1, which is linked to faster aging, especially in large dog breeds.
- LOY-002 is designed for dogs aged 10 and older and weighs more than 14 pounds.
- The drug has passed two of three major FDA approval steps.
- If approved, LOY-002 would be the first FDA-cleared drug to slow aging in animals or humans.
- Loyal, the company behind LOY-002, aims to market the drug by 2026.
- The global pet care market is valued at $261 billion, indicating significant market potential for the drug.
